ENDOSCOPIC SLEEVE GASTROPLASTY FOR OBESE PATIENTS

Abstract

Endoscopic sleeve gastroplasty (ESG) is a newly developed endoscopic bariatric surgery in which the stomach is sewn in full-thickness layers using an endoscopic suturing device to reduce stomach volume. ESG not only achieves a higher weight loss effect, but also has lower invasiveness and complication rates. Recently, ESG has become widespread (mainly in Europe and the United States) as a less invasive new treatment method for obesity. Although the number of obese patients is lower in Japan than in Europe or the United States, Asians tend to develop metabolic syndrome though their absolute BMIs may be low. Therefore, it is expected that ESG will become commonplace and prevalent in Japan as a new treatment option for patients with mild obesity who are not indicated for bariatric surgery or patients who are reluctant to receive surgery.